142 related articles for article (PubMed ID: 35811444)
1. Comment on the risk of hepatocellular carcinoma with chronic hepatitis B infection in Sweden.
Singh SP; Mondia N
Hepatol Commun; 2022 Dec; 6(12):3592. PubMed ID: 35811444
[No Abstract] [Full Text] [Related]
2. Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B.
Huang R; Zhang Z; Wang J; Zhang S; Wu C
Aliment Pharmacol Ther; 2023 Nov; 58(9):965-966. PubMed ID: 37831536
[No Abstract] [Full Text] [Related]
3. Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B.
Zhao J
Aliment Pharmacol Ther; 2023 Nov; 58(9):964. PubMed ID: 37831535
[No Abstract] [Full Text] [Related]
4. Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country.
Davídsdóttir L; Duberg AS; Törner A; Aleman S; Bäck E; Ekdahl K; Blaxhult A; Ekbom A; Hultcrantz R
Scand J Gastroenterol; 2010 Aug; 45(7-8):944-52. PubMed ID: 20384529
[TBL] [Abstract][Full Text] [Related]
5. Letter to the editor: Hepatitis B virus genotype: A significant risk factor in determining which patients with chronic hepatitis B virus infection should undergo surveillance for hepatocellular carcinoma: The hepatitis B Alaska study.
Kumar A; Rajani D; Kumar S
Hepatology; 2022 Sep; 76(3):E63-E64. PubMed ID: 35478185
[No Abstract] [Full Text] [Related]
6. Lack of correlation between hepatitis B virus infection and the increasing incidence of primary liver cancer in Sweden.
Kaczynski J; Hansson G; Norkrans G; Wallerstedt S
Acta Oncol; 1991; 30(7):811-3. PubMed ID: 1662521
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification in chronic hepatitis B patients for hepatocellular carcinoma surveillance: management in migrant sub-Saharan African populations.
Cargill Z; Brown SE; Dusheiko G; Agarwal K
Gut; 2021 Mar; 70(3):629-630. PubMed ID: 32606207
[No Abstract] [Full Text] [Related]
8. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
Ji J; Sundquist K; Sundquist J
J Natl Cancer Inst; 2012 May; 104(10):790-2. PubMed ID: 22423008
[TBL] [Abstract][Full Text] [Related]
9. [Screening and surveillance for hepatocellular carcinoma in patients with chronic hepatitis B virus infection].
Expert Group for Project of Hepatocellular Carcinoma Screening and Surveillance, Chinese Foundation for Hepatitis Prevention and Control
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):932-941. PubMed ID: 34814387
[TBL] [Abstract][Full Text] [Related]
10. [Incidence of hepatocellular carcinoma in chronic infection with hepatitis B].
Ntagirabiri R; Munezero B; Kaze H; Ndirahisha E; Manirakiza S
Pan Afr Med J; 2015; 20():167. PubMed ID: 26113910
[TBL] [Abstract][Full Text] [Related]
11. Editorial: diabetes and its association with hepatocellular carcinoma in chronic hepatitis B.
Konerman M; Loomba R
Aliment Pharmacol Ther; 2015 Jul; 42(1):117-8. PubMed ID: 26040518
[No Abstract] [Full Text] [Related]
12. The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection.
Wen WH; Chang MH; Hsu HY; Ni YH; Chen HL
J Pediatr; 2004 Mar; 144(3):397-9. PubMed ID: 15001956
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma and hepatitis B virus: family matters.
McMahon BJ
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1646-7. PubMed ID: 23735444
[No Abstract] [Full Text] [Related]
14. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
15. Prevention of hepatocellular carcinoma resulting from hepatitis B: are we there yet?
Di Bisceglie AM
Clin Gastroenterol Hepatol; 2014 May; 12(5):894-6. PubMed ID: 24316105
[No Abstract] [Full Text] [Related]
16. Editorial: diabetes and its association with hepatocellular carcinoma in chronic hepatitis B - authors' reply.
Fu SC; Huang YW
Aliment Pharmacol Ther; 2015 Jul; 42(1):118-9. PubMed ID: 26040519
[No Abstract] [Full Text] [Related]
17. Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page?
Sonneveld MJ; Brouwer WP; de Man RA
J Hepatol; 2020 Sep; 73(3):728-729. PubMed ID: 32423630
[No Abstract] [Full Text] [Related]
18. Reply to: "Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page".
Chan HL; Wong VW; Yip TC; Wong GL
J Hepatol; 2020 Sep; 73(3):729-730. PubMed ID: 32423634
[No Abstract] [Full Text] [Related]
19. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
Basyigit S; Sapmaz F
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1230. PubMed ID: 26327502
[No Abstract] [Full Text] [Related]
20. Liver cancer surveillance in people with hepatitis B in Africa.
Ndububa DA
Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):491-492. PubMed ID: 38588692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
